Oklo's Groves-1 test reactor cleared by DOE for unrestricted operations
Oklo said on November 11, 2026 that the U.S. Department of Energy has cleared the final operations hold point for its Groves-1 test reactor in Lockhart, Texas, so the facility can move into research, testing and training work. The step matters to U.S. investors in Oklo (NYSE: OKLO) and in the wider nuclear-power sector, because it is a federal regulatory milestone for a company that has not yet brought a commercial plant online.
What the DOE cleared
Oklo said the Department of Energy has cleared the final operations hold point for the Groves Isotope Test Reactor, known as Groves-1. The company said that, with the facility cleared for unrestricted operations, it can now test capabilities relevant to future isotope reactors and to its fast fission reactor design, the Aurora powerhouse. The announcement was published in a company press release dated November 11, 2026.
Groves-1 operates under DOE authorization through the agency's Reactor Pilot Program. According to the company, the reactor reached first criticality at low power less than a year after groundbreaking. Oklo also said the project showed it could engineer, build, authorize, commission and run a full nuclear facility.
Why the milestone matters for the company
The company said Groves-1 will support criticality and reactivity benchmarking for its isotope production work and for its engineering and design models. Oklo added that the resulting data could also help improve fuel performance and power output in small and large light water reactors.
Oklo also described Groves-1 as a training platform for nuclear personnel who will work at future reactor deployments. Planned equipment testing includes continued evaluation of control rod drive mechanism performance and reliability, according to the release.
Links to isotope production
Operating experience from Groves-1 will feed into Groves-2 Forge, Oklo's planned isotope production and processing pilot facility. The company said Groves-2 Forge was selected under DOE's Nuclear Energy Launch Pad initiative. It is designed to combine reactor irradiation with hot-cell processing, with an initial focus on lutetium-177, an isotope used in targeted cancer treatments.
Official comments
Oklo co-founder and CEO Jacob DeWitte said that taking Groves-1 from greenfield to criticality in under a year showed what the team can accomplish. He said the company is now operating the reactor and learning from that work.
Chimi Zacot, acting Deputy Assistant Secretary for Nuclear Reactors at the DOE, said the Reactor Pilot Program had reset expectations for how quickly advanced reactor designs can move to demonstration while maintaining safety standards.
Market reaction and what remains open
GuruFocus reported that Oklo shares rose in premarket trading following the announcement. The company's release did not include any financial guidance or revenue figures tied to the clearance.
For U.S. investors, the story is mainly a regulatory and operational update for Oklo. It also bears on the broader group of listed nuclear-power developers, since federal clearances under the Reactor Pilot Program are relevant to how quickly advanced reactor projects can progress. The company did not say when its Aurora commercial plant would be built or what its timeline would be for Groves-2 Forge.
Sources
- Oklo stock rises after DOE clears reactor for full operations By Investing.com investing.com
- A Texas nuclear reactor can now test equipment and train workers for future reactors. stocktitan.net
Written with AI assistance on Nov 11, 9:01 AM ET from the reports listed under Sources, and reviewed by our editor after publication. Before it was published, every figure was checked against those reports, and passages with figures that could not be found there were left out. It can still contain mistakes: read the sources before acting on anything. How we review. Not investment advice.